| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/TERM.2506 |
| P698 | PubMed publication ID | 28636192 |
| P50 | author | Christoffer Soendergaard | Q45872519 |
| Fredrik Holmberg Bergenheim | Q60394047 | ||
| Ole Haagen Nielsen | Q37836698 | ||
| Kim B. Jensen | Q38544362 | ||
| P2093 | author name string | Jannie Pedersen | |
| Peter Jørgensen | |||
| P2860 | cites work | Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review | Q22250934 |
| The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells | Q24314491 | ||
| Disrupted barrier function through epithelial cell apoptosis | Q40216846 | ||
| Tissue-specific mutation accumulation in human adult stem cells during life | Q40555695 | ||
| Antimicrobial peptides in gastrointestinal inflammation | Q41477282 | ||
| Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro | Q41770080 | ||
| Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice. | Q41848958 | ||
| NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression | Q41917631 | ||
| Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases | Q42495427 | ||
| "Humanized" stem cell culture techniques: the animal serum controversy | Q42735346 | ||
| Isolation of Human Colon Stem Cells Using Surface Expression of PTK7. | Q43125518 | ||
| Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations | Q44863098 | ||
| Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity. | Q46085911 | ||
| Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. | Q46759429 | ||
| Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis. | Q46958621 | ||
| A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy | Q47968884 | ||
| Prostaglandin E2 promotes intestinal repair through an adaptive cellular response of the epithelium | Q48261865 | ||
| Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis. | Q49696827 | ||
| Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial | Q50232304 | ||
| Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease. | Q50461672 | ||
| Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5⁺ stem cell. | Q50501047 | ||
| Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. | Q50616625 | ||
| Designer matrices for intestinal stem cell and organoid culture. | Q51099747 | ||
| Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. | Q52885366 | ||
| Mucosal Healing in Ulcerative Colitis: A Comprehensive Review. | Q53815697 | ||
| Isolation and in vitro expansion of human colonic stem cells. | Q54350641 | ||
| Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. | Q54544550 | ||
| Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. | Q54762013 | ||
| Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis | Q24537963 | ||
| Reduced Paneth cell alpha-defensins in ileal Crohn's disease | Q24538724 | ||
| Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls | Q26745715 | ||
| Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease | Q26771122 | ||
| Antimicrobial proteins in intestine and inflammatory bowel diseases | Q27023239 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of Bacteria | Q28072687 | ||
| Identification of stem cells in small intestine and colon by marker gene Lgr5 | Q28131701 | ||
| Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system | Q28223769 | ||
| Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche | Q28239639 | ||
| KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation | Q28265962 | ||
| The burden of inflammatory bowel disease in Europe | Q28285200 | ||
| Transcription factor achaete scute-like 2 controls intestinal stem cell fate | Q28507783 | ||
| Human induced pluripotent stem cells free of vector and transgene sequences | Q29547624 | ||
| Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts | Q29616197 | ||
| Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency | Q29616797 | ||
| The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. | Q30499201 | ||
| Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease | Q30519492 | ||
| Canonical Wnt signals combined with suppressed TGFβ/BMP pathways promote renewal of the native human colonic epithelium | Q30574557 | ||
| Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease | Q33249005 | ||
| Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells | Q33296957 | ||
| Matrigel: a complex protein mixture required for optimal growth of cell culture. | Q34021289 | ||
| Interconversion between intestinal stem cell populations in distinct niches | Q34231718 | ||
| The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers | Q34280882 | ||
| The gastrointestinal mucus system in health and disease | Q34332180 | ||
| Intestinal inflammation and mucosal barrier function | Q34438743 | ||
| Single-cell analysis of proxy reporter allele-marked epithelial cells establishes intestinal stem cell hierarchy | Q34530142 | ||
| Clarifying Stem-Cell Therapy's Benefits and Risks | Q34547244 | ||
| Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease | Q34596979 | ||
| Bmi1 is expressed in vivo in intestinal stem cells | Q34785173 | ||
| The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system | Q34798439 | ||
| Intestinal myofibroblasts: targets for stem cell therapy | Q34979983 | ||
| OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells | Q34981596 | ||
| Antigen transport and cytoskeletal characteristics of a distinct enterocyte population in inflammatory bowel diseases | Q35102977 | ||
| Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation | Q35212830 | ||
| Type I collagen as an extracellular matrix for the in vitro growth of human small intestinal epithelium | Q35252580 | ||
| Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics | Q35469739 | ||
| Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa | Q35498107 | ||
| An in vivo model of human small intestine using pluripotent stem cells | Q35533803 | ||
| Diet in the pathogenesis and treatment of inflammatory bowel diseases | Q35537121 | ||
| Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha | Q35597021 | ||
| Transcriptome-wide Analysis Reveals Hallmarks of Human Intestine Development and Maturation In Vitro and In Vivo | Q35754364 | ||
| Cellular and molecular mechanisms of the epithelial repair in IBD. | Q36268040 | ||
| Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration | Q36483525 | ||
| Foxl1-expressing mesenchymal cells constitute the intestinal stem cell niche | Q36635836 | ||
| Wound healing and fibrosis in intestinal disease | Q36685523 | ||
| An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease | Q36778895 | ||
| Cloning and variation of ground state intestinal stem cells | Q36860891 | ||
| REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation | Q36875132 | ||
| Mucosal barrier in ulcerative colitis and Crohn's disease | Q36877117 | ||
| Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury | Q36997442 | ||
| Long-term renewable human intestinal epithelial stem cells as monolayers: A potential for clinical use. | Q37038672 | ||
| Epithelial restitution and wound healing in inflammatory bowel disease | Q37058859 | ||
| Dll1+ secretory progenitor cells revert to stem cells upon crypt damage | Q37211856 | ||
| Intestinal barrier dysfunction in inflammatory bowel diseases. | Q37214839 | ||
| Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon | Q37264185 | ||
| Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases | Q37362459 | ||
| Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury | Q37382294 | ||
| Epithelial tight junctions in intestinal inflammation | Q37524296 | ||
| Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice | Q37548319 | ||
| BMP restricts stemness of intestinal Lgr5+ stem cells by directly suppressing their signature genes | Q37581023 | ||
| Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics | Q37973313 | ||
| Stem cells as treatment in inflammatory bowel disease | Q38072234 | ||
| Mucosal healing in ulcerative colitis: pathophysiology and pharmacology. | Q38086553 | ||
| A gutsy task: generating intestinal tissue from human pluripotent stem cells | Q38093484 | ||
| Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies | Q38125012 | ||
| Tumor necrosis factor inhibitors for inflammatory bowel disease | Q38130537 | ||
| Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease | Q38149113 | ||
| Wnt signaling in adult intestinal stem cells and cancer | Q38168964 | ||
| Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy | Q38223567 | ||
| Mucus layers in inflammatory bowel disease | Q38229690 | ||
| The role and advances of immunomodulator therapy for inflammatory bowel disease | Q38237701 | ||
| Application of biomaterials to advance induced pluripotent stem cell research and therapy | Q38376035 | ||
| Cancers complicating inflammatory bowel disease | Q38411599 | ||
| Paneth cell granule depletion in the human small intestine under infective and nutritional stress | Q38449174 | ||
| Mini-gut organoids: reconstitution of the stem cell niche | Q38599208 | ||
| Iron replacement therapy: do we need new guidelines? | Q38697924 | ||
| Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis | Q38717552 | ||
| Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease | Q38747472 | ||
| Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters | Q38797646 | ||
| Investigating cell therapy for inflammatory bowel disease | Q38817393 | ||
| A practical guide to hydrogels for cell culture | Q38819764 | ||
| Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis | Q38839998 | ||
| Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease. | Q38850512 | ||
| Regulation and plasticity of intestinal stem cells during homeostasis and regeneration | Q38996001 | ||
| Autologous human nasal epithelial cell sheet using temperature-responsive culture insert for transplantation after middle ear surgery | Q39021227 | ||
| Novel Targeted Therapies for Inflammatory Bowel Disease | Q39028822 | ||
| Wnt-expressing cells in the intestines: guides for tissue remodeling | Q39053166 | ||
| Developing Defined and Scalable 3D Culture Systems for Culturing Human Pluripotent Stem Cells at High Densities | Q39094815 | ||
| Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease. | Q39173519 | ||
| Adult stem cells in the small intestine are intrinsically programmed with their location-specific function | Q39256230 | ||
| P433 | issue | 4 | |
| P921 | main subject | inflammation | Q101991 |
| inflammatory bowel diseases | Q917447 | ||
| P304 | page(s) | 923-935 | |
| P577 | publication date | 2017-10-19 | |
| P1433 | published in | Journal of Tissue Engineering and Regenerative Medicine | Q15746559 |
| P1476 | title | Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier | |
| P478 | volume | 12 |
| Q90441607 | Characterization and evolution of intestine injury at the anhepatic phase in portal hypertensive rats |
| Q64107610 | Diet-Related Metabolic Perturbations of Gut Microbial Shikimate Pathway-Tryptamine-tRNA Aminoacylation-Protein Synthesis in Human Health and Disease |
| Q55364545 | Emerging concepts in non-invasive monitoring of Crohn's disease. |
| Q64286948 | Fluorescence-based tracing of transplanted intestinal epithelial cells using confocal laser endomicroscopy |
| Q92659107 | Inhibition of CREB-mediated ZO-1 and activation of NF-κB-induced IL-6 by colonic epithelial MCT4 destroys intestinal barrier function |
| Q47255368 | Intestinal Stem Cells to Advance Drug Development, Precision, and Regenerative Medicine: A Paradigm Shift in Translational Research |
| Q60050046 | Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature |
| Q88961131 | The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics |
| Q60952879 | Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals |
| Q92152294 | [Protective effect of procyanidin B2 on intestinal barrier and against enteritis in a mouse model of trinitrobenzene sulphonic acid-induced colitis] |
Search more.